Tumor Lysis Syndrome following a Single Dose of Nivolumab for Relapsed Small-Cell Lung Cancer

Tumor lysis syndrome (TLS) is an oncologic emergency most frequently associated with initial treatment of hematologic malignancies and high-tumor burden solid tumors such as small-cell lung cancer (SCLC). Most often, TLS is associated with cytotoxic chemotherapy. In the treatment of SCLC, a paradigm...

Full description

Saved in:
Bibliographic Details
Main Authors: Sarah Maryon Hayes, Christine Wiese, Robert Schneidewend
Format: article
Language:EN
Published: Karger Publishers 2021
Subjects:
Online Access:https://doaj.org/article/7f3a540ff9c64291a6565598aaa03d70
Tags: Add Tag
No Tags, Be the first to tag this record!